查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗凝剂市场 - 按药物类别（Xa因子抑制剂、肝素）、给药途径（口服、注射）、应用（血栓栓塞症、心房颤动、冠状动脉疾病）、分销渠道和全球预测，2023 - 2032年
市场调查报告书
商品编码
1305941

抗凝剂市场 - 按药物类别（Xa因子抑制剂、肝素）、给药途径（口服、注射）、应用（血栓栓塞症、心房颤动、冠状动脉疾病）、分销渠道和全球预测，2023 - 2032年

Anticoagulants Market - By Drug Class (Factor Xa Inhibitors, Heparin), Route of Administration (Oral, Injectables), Application (Thromboembolism, Atrial Fibrillation, Coronary Artery Disease), Distribution Channel & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

到2032年，全球抗凝剂市场规模将显著扩大。早期疾病诊断意识的提高为市场增长铺平了道路。由于对疾病诊断的认识不断提高，全球各国政府都在投资筛查项目和常规健康检查，以识别有血栓和相关疾病风险的人群。此外，产品制造商正致力于开发具有先进功能和最大疗效的抗凝剂，以巩固其市场地位。这些因素将共同推动抗凝剂在未来几年的销售。

整个抗凝剂市场根据药物类别、给药途径、应用、销售渠道和地区进行分类。

根据药物类别，肝素细分市场的行业份额将在2023年至2032年期间以丰厚的复合年增长率增长。深静脉血栓、急性冠状动脉综合征、心房颤动、肺栓塞和其他导致血凝块形成的疾病的发病率不断上升，增加了对肝素的需求。据美国肺脏协会统计，仅在美国每年就有约90万人被诊断出肺栓塞。

根据应用，到2032年，心房颤动/扑动领域的抗凝剂市场价值将获得可观的增长。心房颤动发生率的增长增加了对抗凝剂的需求。根据美国疾病预防控制中心（CDC）的数据，美国每年有超过454,000例以心房颤动为主要诊断的患者入院治疗。此外，监管机构对治疗心房颤动的产品批准数量激增也进一步促进了该细分市场的增长。

就分销渠道而言，2022年医院药房占据了抗凝剂市场53.5%的份额。以优惠价格购买药品的便利性增加了患者前往医院药房的次数。此外，全球各地政府对医院基础设施的投资不断增长，进一步增加了医院药房的数量。这些设施提供以患者为中心的护理，并配备了最先进的医疗设备。

从区域角度来看，欧洲抗凝剂市场规模到2032年将达到140亿美元。老年人口的增长及其对慢性疾病的易感性增强了该地区对抗凝剂的需求。心脏病发作、中风等心脏疾病的高发病率进一步提高了产品在欧洲的采用率。该地区也是勃林格殷格翰公司、拜耳股份公司等行业巨头的发源地，这些巨头强调产品创新以在竞争中脱颖而出，这将支持该地区的扩张。

目录

第1章：方法与范围

第2章：执行摘要

第3章：抗凝血剂行业洞察

  • 行业生态系统分析
  • 行业影响因素
    • 增长驱动力
      • 慢性病发病率不断上升
      • 新型口服抗凝药（NOACs）的应用日益广泛
      • 全球老年人口不断增加
    • 行业陷阱与挑战
      • 副作用风险高
      • 严格的监管框架
  • 增长潜力分析
    • 按药物类别
    • 按给药途径
    • 按应用
    • 按销售渠道
  • COVID-19影响分析
  • 监管格局
  • 波特分析
  • PESTEL分析

第四章：2022年竞争格局

  • 公司介绍
  • 2022年公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第五章：抗凝血药物市场规模及预测：按药物类别划分

  • 按药物类别分類的主要趋势
  • Xa因子抑制剂
  • 肝素
  • 华法林
  • 直接凝血酶抑制剂
  • 其他药物

第六章：抗凝剂市场规模及预测：按给药途径分类

  • 按给药途径分類的主要趋势
  • 口服
  • 注射剂

第七章 ：抗凝剂市场规模及预测：按应用分类

  • 按应用分类的主要趋势
  • 静脉血栓栓塞
  • 心房颤动/扑动
  • 冠状动脉疾病
  • 其他

第八章：抗凝剂市场规模及预测：按销售渠道分类

  • 按销售渠道分類的主要趋势
  • 医院药房
  • 零售药店
  • 网上药店

第九章：抗凝血剂市场规模及预测：按地区分类

  • 各地区主要趋势
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第10章：公司简介

  • Bristol-Myers Squibb Company
  • Bayer AG
  • Boehringer Ingelheim
  • Johnson and Johnson
  • Daiichi Sankyo Company
  • Amphastar Pharmaceuticals, Inc.
  • Leo pharma
  • Pfizer
  • ROVI
  • Sanofi
  • Shenzhen Hepalink
  • United Therapeutics
Product Code: 4967

Global Anticoagulants Market size will expand significantly through 2032. Rising awareness about early disease diagnosis is paving the path for market growth. Owing to growing awareness about disease diagnosis, governments across the globe are investing in screening programs and routine health check-ups to identify individuals at risk of developing blood clots and related disorders. Besides, product manufacturers are focusing on developing anticoagulants with advanced capabilities and maximum efficacy to strengthen their market position. These factors, in tandem, will propel anticoagulant sales over the coming years.

The overall anticoagulants market is classified based on drug category, route of administration, application, distribution channel, and region.

Based on the drug category, industry share from the heparin segment will grow at a lucrative CAGR from 2023 to 2032. Increasing prevalence of deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and other disorders that lead to blood clot formation has increased the need for heparin. As per the American Lung Association, pulmonary embolism is diagnosed in around 900,000 people every year in the U.S. alone.

Based on application, the anticoagulants market value from the atrial fibrillation/Flutter segment will register considerable gains through 2032. Growing occurrence of atrial fibrillation has increased the need for anticoagulants. As per CDC, over 454,000 hospital admissions with atrial fibrillation as the primary diagnosis take place every year in the U.S. Moreover, surging product approvals by regulatory bodies for the treatment of this disease are further working in favor of segment growth.

In terms of distribution channel, the hospital pharmacy segment amassed over 53.5% of the anticoagulants market share in 2022. The ease of availability of medicines at discounted prices has increased patient visits to hospital pharmacies. Moreover, growing investment by governments across the globe in hospital infrastructure has further increased the number of hospital pharmacies. These facilities offer patient-centered care and are equipped with cutting-edge medical equipment.

From the regional perspective, Europe anticoagulants market size will reach USD 14 billion by 2032. Growing geriatric population and its susceptibility to chronic ailments have bolstered the need for anticoagulants in the region. The high burden of heart diseases such as heart attack, stroke, and others has further increased product adoption in Europe. The region is also home to industry giants, such as Boehringer Ingelheim, Bayer AG, and others, emphasizing product innovations to stand out in the competition, which will support regional expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Anticoagulants industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug category trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Application trends
    • 2.1.6 Distribution channel trends

Chapter 3 Anticoagulants Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of chronic disease
      • 3.2.1.2 Growing adoption of novel oral anticoagulants (NOACs)
      • 3.2.1.3 Rising geriatric population across the globe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High risk of side effects
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
    • 3.3.1 By drug category
    • 3.3.2 By route of administration
    • 3.3.3 By application
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Anticoagulants Market Size and Forecast, By Drug Category (USD Million)

  • 5.1 Key trends, by drug category
  • 5.2 Factor Xa inhibitor
  • 5.3 Heparin
  • 5.4 Warfarin
  • 5.5 Direct thrombin inhibitor
  • 5.6 Others

Chapter 6 Anticoagulants Market Size and Forecast, By Route of Administration (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Oral
  • 6.3 Injectable

Chapter 7 Anticoagulants Market Size and Forecast, By Application (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Venous thromboembolism
  • 7.3 Atrial fibrillation/flutter
  • 7.4 Coronary artery disease
  • 7.5 Others

Chapter 8 Anticoagulants Market Size and Forecast, By Distribution Channel (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Anticoagulants Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Bristol-Myers Squibb Company
  • 10.2 Bayer AG
  • 10.3 Boehringer Ingelheim
  • 10.4 Johnson and Johnson
  • 10.5 Daiichi Sankyo Company
  • 10.6 Amphastar Pharmaceuticals, Inc.
  • 10.7 Leo pharma
  • 10.8 Pfizer
  • 10.9 ROVI
  • 10.10 Sanofi
  • 10.11 Shenzhen Hepalink
  • 10.12 United Therapeutics

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug category (2022)
  • TABLE 3 Market revenue, by route of administration (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market share, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global anticoagulants market size, by drug category, 2018 - 2022 (USD Million)
  • TABLE 8 Global anticoagulants market size, by drug category, 2023 - 2032 (USD Million)
  • TABLE 9 Global anticoagulants market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 10 Global anticoagulants market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 11 Global anticoagulants market size, by application, 2018 - 2022 (USD Million)
  • TABLE 12 Global anticoagulants market size, by application, 2023 - 2032 (USD Million)
  • TABLE 13 Global nutraceuticals market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 14 Global nutraceuticals market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 15 Industry impact forces
  • TABLE 16 Factor Xa inhibitors market, by region, 2018 - 2022, (USD Million)
  • TABLE 17 Factor Xa inhibitors market, by region, 2023 - 2032, (USD Million)
  • TABLE 18 Heparin market, by region, 2018 - 2022, (USD Million)
  • TABLE 19 Heparin market, by region, 2023 - 2032, (USD Million)
  • TABLE 20 Warfarin market, by region, 2018 - 2022, (USD Million)
  • TABLE 21 Warfarin market, by region, 2023 - 2032, (USD Million)
  • TABLE 22 Direct thrombin inhibitors market, by region, 2018 - 2022, (USD Million)
  • TABLE 23 Direct thrombin inhibitors market, by region, 2023 - 2032, (USD Million)
  • TABLE 24 Others market, by region, 2018 - 2022, (USD Million)
  • TABLE 25 Others market, by region, 2023 - 2032, (USD Million)
  • TABLE 26 Oral market, by region, 2018 - 2022, (USD Million)
  • TABLE 27 Oral market, by region, 2023 - 2032, (USD Million)
  • TABLE 28 Injectable market, by region, 2018 - 2022, (USD Million)
  • TABLE 29 Injectable market, by region, 2023 - 2032, (USD Million)
  • TABLE 30 Venous thromboembolism market, by region, 2018 - 2022, (USD Million)
  • TABLE 31 Venous thromboembolism market, by region, 2023 - 2032, (USD Million)
  • TABLE 32 Atrial fibrillation/flutter market, by region, 2018 - 2022, (USD Million)
  • TABLE 33 Atrial fibrillation/flutter market, by region, 2023 - 2032, (USD Million)
  • TABLE 34 Coronary artery disease market, by region, 2018 - 2022, (USD Million)
  • TABLE 35 Coronary artery disease market, by region, 2023 - 2032, (USD Million)
  • TABLE 36 Others market, by region, 2018 - 2022, (USD Million)
  • TABLE 37 Others market, by region, 2023 - 2032, (USD Million)
  • TABLE 38 Hospital pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 39 Hospital pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 40 Retail pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 41 Retail pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 42 Online pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 43 Online pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 44 North America anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 45 North America anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 46 North America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 47 North America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 48 North America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 49 North America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 50 North America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 51 North America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 52 North America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 53 North America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 54 U.S. anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 55 U.S. anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 56 U.S. anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 57 U.S. anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 58 U.S. anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 59 U.S. anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 60 U.S. anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 61 U.S. anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 62 Canada anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 63 Canada anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 64 Canada anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 65 Canada anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 66 Canada anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 67 Canada anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 68 Canada ca anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 69 Canada anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 70 Europe anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 71 Europe anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 72 Europe anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 73 Europe anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 74 Europe anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 75 Europe anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 76 Europe anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 77 Europe anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 78 Europe anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 79 Europe anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 80 Germany anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 81 Germany anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 82 Germany anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 83 Germany anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 84 Germany anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 85 Germany anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 86 Germany anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 87 Germany anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 88 UK anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 89 UK anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 90 UK anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 91 UK anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 92 UK anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 93 UK anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 94 UK ca anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 95 UK anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 96 France anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 97 France anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 98 France anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 99 France anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 100 France anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 101 France anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 102 France anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 103 France anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 104 Italy anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 105 Italy anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 106 Italy anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 107 Italy anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 108 Italy anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 109 Italy anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 110 Italy anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 111 Italy anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 112 Spain anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 113 Spain anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 114 Spain anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 115 Spain anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 116 Spain anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 117 Spain anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 118 Spain anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 119 Spain anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 120 Rest of Europe anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 121 Rest of Europe anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 122 Rest of Europe anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 123 Rest of Europe anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 124 Rest of Europe anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 125 Rest of Europe anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 126 Rest of Europe anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 127 Asia Pacific anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 128 Asia Pacific anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 129 Asia Pacific anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 130 Asia Pacific anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 131 Asia Pacific anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 132 Asia Pacific anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 133 Asia Pacific anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 134 Asia Pacific anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 135 Asia Pacific anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 136 Asia Pacific anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 137 Japan anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 138 Japan anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 139 Japan anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 140 Japan anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 141 Japan anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 142 Japan anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 143 Japan anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 144 Japan anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 145 China anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 146 China anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 147 China anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 148 China anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 149 China anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 150 China anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 151 China anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 152 China anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 153 India anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 154 India anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 155 India anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 156 India anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 157 India anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 158 India anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 159 India anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 160 India anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 161 Australia anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 162 Australia anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 163 Australia anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 164 Australia anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 165 Australia anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 166 Australia anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 167 Australia anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 168 Australia anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 169 Rest of Asia Pacific anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 170 Rest of Asia Pacific anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 171 Rest of Asia Pacific anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 172 Rest of Asia Pacific anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 173 Rest of Asia Pacific anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 174 Rest of Asia Pacific anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 175 Rest of Asia Pacific anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 176 Rest of Asia Pacific anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 177 Latin America anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 178 Latin America anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 179 Latin America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 180 Latin America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 181 Latin America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 182 Latin America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 183 Latin America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 184 Latin America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 185 Latin America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 186 Latin America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 187 Brazil anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 188 Brazil anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 189 Brazil anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 190 Brazil anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 191 Brazil anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 192 Brazil anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 193 Brazil anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 194 Brazil anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 195 Mexico anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 196 Mexico anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 197 Mexico anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 198 Mexico anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 199 Mexico anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 200 Mexico anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 201 Mexico anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 202 Mexico anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 203 Argentina anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 204 Argentina anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 205 Argentina anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 206 Argentina anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 207 Argentina anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 208 Argentina anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 209 Argentina anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 210 Argentina anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 211 Rest of Latin America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 212 Rest of Latin America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 213 Rest of Latin America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 214 Rest of Latin America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 215 Rest of Latin America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 216 Rest of Latin America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 217 Rest of Latin America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 218 Rest of Latin America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 219 MEA anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 220 MEA anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 221 MEA anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 222 MEA anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 223 MEA anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 224 MEA anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 225 MEA anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 226 MEA anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 227 MEA anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 228 MEA anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 229 South Africa anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 230 South Africa anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 231 South Africa anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 232 South Africa anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 233 South Africa anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 234 South Africa anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 235 South Africa anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 236 South Africa anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 237 Saudi Arabia anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 238 Saudi Arabia anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 239 Saudi Arabia anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 240 Saudi Arabia anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 241 Saudi Arabia anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 242 Saudi Arabia anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 243 Saudi Arabia anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 244 Saudi Arabia anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 245 UAE anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 246 UAE anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 247 UAE anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 248 UAE anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 249 UAE anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 250 UAE anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 251 UAE anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 252 UAE anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 253 Rest of MEA anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 254 Rest of MEA anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 255 Rest of MEA anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 256 Rest of MEA anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 257 Rest of MEA anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 258 Rest of MEA anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 259 Rest of MEA anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 260 Rest of MEA anticoagulants market, by distribution channel, 2023-2032, (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Anticoagulants industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug category
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022